AzTrials
AzTrials

StrokeNCT00771771

Early Supported Discharge After Stroke in Bergen

A study testing Early supported discharge with day unit rehabilitation and Early supported discharge with home rehabilitation in people with Stroke, run by Haukeland University Hospital at 1 site in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The main purpose of this study is to evaluate the benefit of early supported discharge (ESD) in rehabilitation of stroke patients in two different outpatient modalities. In a collaborating study, changes in physical function as well as the patients' own perception of physical function, pain and fatigue will be… Read more about this study

Who is it for?
Any age
Conditions the study is for
Stroke
What is being tested?
Early supported discharge with day unit rehabilitation and Early supported discharge with home rehabilitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
306 participants
Where
1 siteNorway
Study dates
Dec 2008to Dec 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Living in own home in the community of Bergen, Norway
  • Inclusion within 1-7 days (24-168 hours) after debut of symptoms
  • Inclusion within 6-120 hours after admission to Department of Neurology
  • NIHSS score 2-26 at inclusion OR NIHSS score < 2 if Modified Rankin Scale is 2 or higher when being 0 before the stroke
  • The patient must be awake and informed consent must be given by patient or relatives

Who cannot join

  • Serious psychic illness
  • Serious drug abuse
  • Serious medical conditions that can influence the patients' cerebrovascular disease or rehabilitation
  • Poor knowledge of the Norwegian language

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • Haukeland University Hospital

    Bergen, N-5021

Other trials in Norway

About this study

Official title: Early Supported Discharge After Stroke in Bergen. An RCT Looking at the Collaboration Between Hospital Service and Primary Health Care.

The main purpose of this study is to evaluate the benefit of early supported discharge (ESD) in rehabilitation of stroke patients in two different outpatient modalities.

In a collaborating study, changes in physical function as well as the patients' own perception of physical function, pain and fatigue will be studied. In further collaborating studies, health economics and organizational issues will also be evaluated.

Read the detailed description

Early supported discharge (ESD) seems to be at least as effective as hospital rehabilitation after stroke, and possibly better. In this study patients with recent stroke will be randomized to one of three different treatment arms:

  • ESD with treatment at a day institution until 4 hrs. per day for up to 5 weeks
  • ESD with treatment in the patients' home until 4 hrs. per day for up to 5 weeks
  • Rehabilitation treatment "as usual", with a longer hospital stay, but without any specific treatment or follow-up after discharge

The patients in the two ESD arms will in addition be followed closely by a multidisciplinary coordinating team during the stay in hospital and the 5 week period of treatment after discharge, and they will be offered follow-ups at 3 and 6 months after inclusion into the study.

Patients in all 3 arms will be systematically examined with a set of measuring instruments as well as objective physical and function tests. This will be performed at inclusion and at 3, 6, 12 and 24 months after inclusion.

In the collaborating study by physiotherapist Bente Gjelsvik a comparison between changes in trunk control, balance, walking and ADL 3 months post stroke, as well as the patients' perceptions of physical function, pain and fatigue, will be the main focus. To assess function, functional change and possible differences between different interventions, there is a need for reliable and valid outcome measures. As a basis for the use of the outcome measure Trunk Impairment Scale (TIS) in this study, the TIS has been translated into Norwegian, Trunk Impairment Scale - Norwegian version (TIS-NV) and will be examined for measurement properties using data from the above study as well as data from patients with brain damage recruited from the Department of Physical Rehabilitation Medicine, Haukeland University Hospital. An examination of a possible connection between localisation and size of the stroke and trunk control will also be performed, as characteristics of the stroke may have therapeutic implications for the choice of intervention for the individual patient. The research questions for the planned doctoral thesis for Bente Gjelsvik are therefore as follows:

  1. Is the TIS-NV reliable and valid in patients with brain damage?
  2. Are changes in trunk control, balance, walking and daily activities, as well as pain and fatigue 3 months post stroke different in patients who have received interventions from different courses of rehabilitation in the study "Early supported discharge after stroke in Bergen"? To which degree do the patients perceive problems related to balance, physical activity, walking, pain and fatigue?
  3. Is there a correlation between localization and size of the stroke as measured by magnetic tomography, and the patients' trunk control? Are initial localization and size of the stroke predictive for the patients' trunk control 3 months post stroke?

Another collaborating project is carried out by PhD candidate Hedda Døli (Language outcome after stroke: lesion location, prognosis and consequences).

The aim of her first study in the PhD project is to investigate the relationship between lesion location and aphasia severity one week post-stroke. Thereafter a follow-up study of the same patients 12 months post-stroke investigates the prognosis of aphasia and the variables that may influence recovery. In the third study the aim is to investigate the health-related quality of life and the occurrence of depression in patients with aphasia.

Conditions
Stroke
Being tested
Early supported discharge with day unit rehabilitation, Early supported discharge with home rehabilitation
Keywords
Stroke, Rehabilitation, Early Supported Discharge, ESD, RCT
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Early supported discharge with day unit rehabilitationOther

    Treatment by physiotherapist and occupational therapist up to 4 hours a day for up to 5 weeks in a day unit

  • Early supported discharge with home rehabilitationOther

    Treatment by physiotherapist and occupational therapist up to 4 hours a day for up to 5 weeks in the patient's home

Study groups in NCT00771771
Study groupRoleWhat they receive
Day unit rehabilitationActive comparatorDischarge from the hospital to the patients' homes as soon as possible, supported by an out-patient ambulatory coordinating multidisciplinary team. The patients will be offered rehabilitation in a day unit, and multidisciplinary policlinical follow-ups will be performed 3 and 6 months after inclusion.
Receives: Other: Early supported discharge with day unit rehabilitation
Home rehabilitationActive comparatorDischarge from the hospital to the patients' homes as soon as possible, supported by an out-patient ambulatory coordinating multidisciplinary team. The patients will be offered rehabilitation treatment in their homes, and multidisciplinary policlinical follow-ups will be performed 3 and 6 months after inclusion.
Receives: Other: Early supported discharge with home rehabilitation
Treatment as usualNo interventionPatients will receive rehabilitation treatment after today's principles and routines.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. MRS

    Modified Rankin Scale

    Measured: 6 months

Secondary outcomes (14)
  1. NIHSS

    National Institutes of Health Stroke Scale

    Measured: 3, 6 and 12 months

  2. BI

    Barthel ADL Index

    Measured: 3, 6, 12 and 24 months

  3. AMPS

    Assessment of Motor and Process Skills

    Measured: 3 and 6 months

  4. TIS

    Trunk Impairment Scale

    Measured: 3 and 6 months

  5. SIS

    Stroke Impact Scale

    Measured: 12 months

  6. RSS

    Relative Stress Scale

    Measured: 12 months

  7. PGIC

    Patients' Global Impression of Change

    Measured: 12 and 24 months

  8. SF-36

    Short Form (36) Health Survey

    Measured: 12 and 24 months

  9. MRS

    Modified Rankin Scale

    Measured: 3, 12 and 24 months

  10. PASS (Postural Assessment Scale for Stroke)

    Measured: 3 and 6 months

  11. 5mTW (5 meter Timed Walk)

    Measured: 3 and 6 months

  12. TUG (Timed Up and Go)

    Measured: 3 and 6 months

  13. NRS (Numeric Rating Scale)

    Measured: 3 and 6 months

  14. Norwegian Basic Test for Aphasia

    Measured: 3 and 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Oct 2008 (estimated)
  2. Study startDec 2008
  3. Primary completionJun 2012
  4. Study completionDec 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
306 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00771771
Sponsor's protocol ID
18993
Status last verified
Feb 2014
First submitted
10 Oct 2008
Last updated
25 Feb 2014
Results posted
No
Data monitoring committee
No

Publications

  • Hofstad H, Naess H, Moe-Nilssen R, Skouen JS. Early supported discharge after stroke in Bergen (ESD Stroke Bergen): a randomized controlled trial comparing rehabilitation in a day unit or in the patients' homes with conventional treatment. Int J Stroke. 2013 Oct;8(7):582-7. doi: 10.1111/j.1747-4949.2012.00825.x. Epub 2012 May 18.

    PubMed 22594689
  • Gjelsvik B, Breivik K, Verheyden G, Smedal T, Hofstad H, Strand LI. The Trunk Impairment Scale - modified to ordinal scales in the Norwegian version. Disabil Rehabil. 2012;34(16):1385-95. doi: 10.3109/09638288.2011.645113. Epub 2011 Dec 23.

    PubMed 22191850
  • Hofstad H, Gjelsvik BE, Naess H, Eide GE, Skouen JS. Early supported discharge after stroke in Bergen (ESD Stroke Bergen): three and six months results of a randomised controlled trial comparing two early supported discharge schemes with treatment as usual. BMC Neurol. 2014 Dec 21;14:239. doi: 10.1186/s12883-014-0239-3.

    PubMed 25528166
  • Gjelsvik BE, Hofstad H, Smedal T, Eide GE, Naess H, Skouen JS, Frisk B, Daltveit S, Strand LI. Balance and walking after three different models of stroke rehabilitation: early supported discharge in a day unit or at home, and traditional treatment (control). BMJ Open. 2014 May 14;4(5):e004358. doi: 10.1136/bmjopen-2013-004358.

    PubMed 24833680

Questions about this trial

What is this clinical trial studying?

A study testing Early supported discharge with day unit rehabilitation and Early supported discharge with home rehabilitation in people with Stroke, run by Haukeland University Hospital at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Feb 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

MRS (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00771771, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Feb 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in